Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C010914 |
2,4-diaminotoluene |
2,4-diaminotoluene results in increased expression of HMGA2 mRNA | increases expression | 20713471
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of HMGA2 mRNA | decreases expression | 18648102
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased expression of HMGA2 mRNA | increases expression | 18687144
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of HMGA2 mRNA | decreases expression | 20382639
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of HMGA2 mRNA | increases expression | 14729362
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of HMGA2 mRNA | increases expression | 17854601
|
D004052 |
Diethylnitrosamine |
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of HMGA2 mRNA] | decreases reaction|increases expression | 17854601
|
D004317 |
Doxorubicin |
HMGA2 protein affects the susceptibility to Doxorubicin | affects response to substance | 16217747
|
D005047 |
Etoposide |
HMGA2 protein affects the susceptibility to Etoposide | affects response to substance | 16217747
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in increased expression of HMGA2 mRNA | increases expression | 20713471
|
D016685 |
Mitomycin |
HMGA2 protein affects the susceptibility to Mitomycin | affects response to substance | 16217747
|
D011374 |
Progesterone |
NCOA2 protein affects the reaction [Progesterone results in decreased expression of HMGA2 mRNA] | affects reaction|decreases expression | 17556502
|
D011374 |
Progesterone |
Progesterone results in decreased expression of HMGA2 mRNA | decreases expression | 17556502
|
D011374 |
Progesterone |
Progesterone results in increased expression of HMGA2 | increases expression | 17510236
|
D020849 |
Raloxifene |
Raloxifene affects the expression of HMGA2 mRNA | affects expression | 14699072
|
D019772 |
Topotecan |
HMGA2 protein affects the susceptibility to Topotecan | affects response to substance | 16217747
|
C496197 |
trans-10,cis-12-conjugated linoleic acid |
trans-10,cis-12-conjugated linoleic acid results in increased expression of HMGA2 mRNA | increases expression | 17951470
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of HMGA2 mRNA | decreases expression | 16604517
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
2.57 | 17418594 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
11.34 | 3712494 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
11.34 | 6695378 10737359 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
11.34 | 10545420 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
3.95 | 19052882 17620307 17162532 19061943 18056438 16434500 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
11.58 | 21441931 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
11.58 | 17308373 17451421 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.64 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.55 | 15800139 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.09 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.27 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.35 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
3.47 | 11922910 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.44 | 16935849 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
5.08 | 11289319 1440618 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
3.64 | 16197459 16206674 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
12.37 | 14601052 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Etoposide |
12.37 | 14601052 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.40 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
11.11 | 15665606 15380490 15845082 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
11.11 | 16580743 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.84 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
2,4-diaminotoluene |
4.77 | 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
4.77 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
4.77 | 15136595 15692762 18695136 15993339 15939500 17983394 18628466 17369602 16264153 18234424 16096432 15994142 19526202 17426702 16115903 18382427 15567936 11325840 15668708 16935488 15634643 16595493 16826403 16322301 |
MESH:D001943 |
Breast Neoplasms |
|
Etoposide |
4.77 | 16322251 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
4.77 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
4.77 | 16175315 15562024 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
4.77 | 17440819 15758505 17242785 17893378 17049068 16912660 17261762 15572757 17595753 15775269 17952589 16837676 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
4.77 | 16873071 16443354 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.64 | 16813970 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.87 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
3.99 | 10545420 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.22 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
6.63 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
6.63 | 10672840 20007298 17761372 18971187 3084413 18785209 16288022 10737359 17978847 16540662 17173139 18056438 16935385 11831363 20214788 21159647 19919837 19335982 19701751 19822196 19052882 20524982 18506893 3581430 19171122 16779866 20727157 19383236 16569478 17428255 17055752 20432363 19539802 20512989 18393292 16698587 19208518 16807293 18210153 20101231 17138121 20084675 16878318 18978308 16328049 20935162 16502159 16681979 18788625 19394651 20514400 16830150 18691550 18494052 18665156 19107877 19418558 17162532 19519916 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
6.63 | 18059187 16234567 16023760 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
6.63 | 1917145 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
6.59 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
6.59 | 1485588 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
4.81 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.81 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
4.10 | 17572228 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.55 | 17007740 16269455 17924179 17382496 15811867 15792986 16278810 16651473 16952015 16364871 17974986 17351982 16242529 15476868 17928571 17519947 16612575 17131338 16455267 17308081 15505089 17329180 16731534 16109756 18627295 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.95 | 17334414 16243910 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.46 | 15775269 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.11 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
16.22 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
16.22 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
16.22 | 17174075 2727394 21159647 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
16.22 | 16192471 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.64 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.71 | 19052882 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
3.17 | 19486331 9022650 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.22 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.68 | 9407595 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.66 | 15800139 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.75 | 17035595 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18802399 18259882 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.82 | 17551590 9224671 16925845 8800419 10589399 14991402 9142499 9211117 9125849 9664655 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.19 | 17474826 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.84 | 18759878 11298694 8156756 8970840 12868966 14531868 2524372 11906362 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.52 | 2952479 3621924 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
2.20 | 20387270 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
3.96 | 15920148 17308373 17451421 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.53 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
6.35 | 9653073 18289764 11289319 18692083 8291058 16192314 1440618 9328219 9022650 6482804 18648102 6679447 7440962 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
6.35 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
6.35 | 17416283 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.69 | 18602426 |
MESH:D004487 |
Edema |
|
Raloxifene |
3.37 | 15860553 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.53 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
9.45 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
9.45 | 15845917 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
7.65 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.65 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
3.79 | 16134523 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.22 | 18037988 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.18 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.41 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.41 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.60 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
8.09 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
8.09 | 17473493 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
5.08 | 6705139 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.64 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
4.99 | 10962813 14633661 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
3.55 | 17994277 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
7.30 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
7.30 | 17312396 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
4.07 | 7505956 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
7.91 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.91 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.22 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
2.91 | 14991402 9664655 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
7.90 | 16244372 12587719 17875725 18674790 18006777 16144979 14766674 17888722 16879835 16707910 16495754 16330681 16244371 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
7.90 | 11110106 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.36 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.93 | 15692506 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.55 | 6705139 |
MESH:D006561 |
Herpes Simplex |
|
Etoposide |
4.61 | 10809021 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
7.82 | 17606976 15147373 18501091 |
MESH:D006689 |
Hodgkin Disease |
|
Etoposide |
7.82 | 18180244 16200630 16135485 17606976 15147373 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.23 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.61 | 16778211 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.98 | 15034207 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
2.87 | 17577099 15787275 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.44 | 15869954 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
5.21 | 18785209 |
MESH:D007249 |
Inflammation |
|
Progesterone |
5.21 | 15869954 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.81 | 17994277 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
5.08 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
3.93 | 17551590 15992940 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
3.07 | 15699352 16775033 15369732 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.18 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.99 | 6582329 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.53 | 16973256 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.78 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.22 | 16085563 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.73 | 16932348 16482212 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.08 | 17596541 16294345 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.17 | 19225113 16823087 17506722 19075265 19029980 9834237 15748426 17361223 16331271 17294898 16140955 17107899 17301526 17712046 17368321 16766008 16935935 16891316 17217047 17649720 12679006 17339181 16788101 19035177 19642359 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.33 | 9224671 |
MESH:D008067 |
Lipoma |
marker/mechanism |
|
| |
MESH:D008068 |
Lipomatosis |
marker/mechanism |
|
| |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.84 | 18522880 19638242 20032147 18407596 18665156 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.21 | 9327722 15034207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.65 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
2.65 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.11 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
5.00 | 19426721 20492335 18644402 20583210 19294768 19073162 18977376 20434301 18648771 10737359 21278145 21167192 12771043 19427195 19690152 20405173 20101389 21071580 20137499 2862719 19499222 21047994 19638242 2422723 20452335 19642983 19254457 19551842 15175105 9163691 18754104 19090486 12112319 15885732 19812893 20501860 18978307 19850985 20118626 19996281 19256749 19833225 16942905 19255062 |
MESH:D008113 |
Liver Neoplasms |
|
Mitomycin |
5.00 | 15113037 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
14.33 | 6587162 598648 1399818 3712494 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
14.33 | 18253720 18775883 16842330 18079962 18282651 18544905 2563599 19539802 19126423 19009564 18093689 21159647 18308698 16267830 17942915 19004024 19519916 9362446 3124819 17854601 18164116 17174075 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
14.33 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
14.33 | 1399818 598648 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
4.06 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
3.60 | 20970405 6695378 21163286 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
3.60 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
3.60 | 20512841 9230183 21163286 16337739 6695378 20970405 17909032 16271038 10545420 15390079 1399818 7750092 11893704 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
7.98 | 16098063 |
MESH:D008223 |
Lymphoma |
|
Etoposide |
7.98 | 12854902 12556972 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.81 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.61 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
2,4-diaminotoluene |
10.27 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
10.27 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
10.27 | 17203775 11408345 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.79 | 17453147 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
3.45 | 16827129 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
3.45 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.47 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
6.47 | 16166281 16966607 18303189 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
6.47 | 17638057 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.53 | 15792986 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.62 | 15863610 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.84 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.46 | 16497877 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.09 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
2.96 | 19429709 15857846 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.62 | 16343187 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
9.58 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
9.58 | 9029167 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
9.58 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
2.42 | 16594593 16946489 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.81 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.02 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
3.81 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
7.29 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
7.29 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
7.34 | 15555623 |
MESH:D009447 |
Neuroblastoma |
|
Topotecan |
7.34 | 15176712 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.36 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.18 | 20387270 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.45 | 4026338 6482804 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
5.08 | 3988306 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.41 | 17882678 15775268 19059307 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.26 | 17823083 15758505 17893378 15579764 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.13 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
4.94 | 17393432 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
4.94 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.92 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
12.50 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Etoposide |
12.50 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Mitomycin |
12.50 | 15113037 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
12.50 | 15976015 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.52 | 7296757 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.53 | 6228378 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.22 | 17983394 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.93 | 10923243 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.22 | 17638057 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.58 | 2563599 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.77 | 16888761 15897917 15749863 18437689 16868541 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
Etoposide |
2.77 | 17172428 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.77 | 15731164 16220300 16536755 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.64 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.84 | 16723453 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
3.04 | 17365031 17322281 17975199 15814490 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.62 | 15770314 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.26 | 17922066 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.39 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.13 | 16283617 16116481 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.86 | 18045962 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.01 | 16767912 17203757 15625365 18313854 17710206 15675481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
10.67 | 14601052 16326096 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Etoposide |
10.67 | 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.84 | 17846226 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
9.63 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
9.63 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
9.63 | 16467112 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.61 | 17203757 16767912 15625365 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.33 | 15862959 16503802 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.42 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.42 | 17261132 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.84 | 16837676 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
17.30 | 3712494 6582329 1399818 7505956 6587162 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
17.30 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
17.30 | 17909728 16010429 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
17.30 | 17045167 16026305 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
5.27 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.81 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.24 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
8.47 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
8.47 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
8.47 | 17572228 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.70 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.67 | 16752155 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.27 | 16837676 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.26 | 16364871 17678736 17638931 17334414 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.09 | 16761959 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.62 | 16343187 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.99 | 16287080 |